Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Masimo CorporationNASDAQ: MASI

Total Equity · Q1 FY2026 · quarter ended Apr 2026

Total equity falls 16.6% from a year ago

Total equity stood at $788.9M at the end of Q1 FY2026, down 16.6% from a year earlier and up 9.4% from the prior quarter. Over 3 fiscal years it compounded at -18.6% a year.

Context

  • Total equity amounted to 48.0% of total assets at the end of Q1 FY2026, up 6.8 pp from a year earlier.
  • Total equity increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -16.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
$788.9M+9.4% QoQ
Last fiscal yearJan 2026
$721.2M-31.4% YoY
Year agoMar 2025
$946.4M-16.6% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-16.6%——
1 year-31.4%——
3-year CAGR-18.6%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
721.2M USD
Year-over-year change
-31.4%
4-year CAGR
-17.4%

Total Equity vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -16.6% is the 10th highest of 11, against a peer median of -1.2%.
  • Total equity amounts to 48.0% of total assets for MASI, versus a peer median of 50.3%.
MASI Competitors
Total Equity for MASI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BIOBio-Rad Laboratories, Inc.Jun 2026$7.17B USD+0.6%-8.1%70.0%
BAXBaxter International Inc.Jun 2026$6.18B USD-15.3%+1.2%31.2%
AVTRAvantor, Inc.Jun 2026$5.63B USD-10.4%+4.7%48.6%
HSICHenry Schein, Inc.Jun 2026$4.72B USD-3.6%+0.9%41.5%
MOHMolina Healthcare, Inc.Sep 2026$4.16B USD-0.9%+11.1%26.5%
ATRAptarGroup, Inc.Jun 2026$2.67B USD-1.6%+9.5%52.1%
RGENRepligen CorporationJun 2026$2.11B USD+2.4%+3.3%71.6%
STVNStevanato Group S.p.A.Jun 2026€1.55B EUR+10.9%+14.3%59.2%
MASIMasimo CorporationApr 2026$788.9M USD-16.6%-18.6%48.0%
ABVXAbivax S.A.Jun 2026€366.27M EUR+858.6%+298.5%79.2%
RYTMRhythm Pharmaceuticals, Inc.Sep 2026$201.54M USD-31.8%+0.7%45.5%
Peer median (excluding MASI) —-1.2%+4.0%50.3%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Cash & Equivalents745.3M202.9M163M177.6M152.3M
Short-term Investments00000
Net Receivables244.69M505.1M421M489.3M327.5M
Inventory201.4M501M545M459.2M380.3M
Other Current Assets6.7M6M10.5M24.4M3.9M
Total Current Assets1.24B1.31B1.23B1.23B926M
Property, Plant & Equipment (Net)303.3M472.1M483.5M456M355.1M
Goodwill100.3M445.4M407.7M96.7M101M
Intangible Assets72.5M722.6M652.3M558.2M52.1M
Long-term Investments13.8M13.8M9.9M8.6M71.3M
Tax Assets52.6M102.5M107.2M143.6M114.2M
Other Non-current Assets105.6M145.6M149M136.8M79.2M
Total Non-current Assets648.1M1.9B1.81B1.4B772.9M
Total Assets1.89B3.21B3.04B2.63B1.7B
Account Payables75.6M276.8M251.5M252.8M103M
Short-term Debt015.1M34.3M37.3M6.3M
Tax Payables30.3M72.4M50.2M55.5M0
Deferred Revenue29.9M36M37.4M46.8M38.5M
Other Current Liabilities75.5M95.4M69.3M93.2M88.4M
Total Current Liabilities267.7M630M563.8M617.7M371.6M
Long-term Debt0941.6M871.7M727.9M518M
Deferred Tax Liabilities5.1M163.6M111.7M100.1M26.4M
Deferred Revenue (Non-current)5.2M25M26.4M27.4M23M
Other Non-current Liabilities32.5M58.1M57.3M41.2M11.8M
Total Non-current Liabilities69.1M1.24B1.11B956.1M606.1M
Total Liabilities336.8M1.87B1.68B1.57B977.7M
Common Stock100K100K100K100K100K
Retained Earnings1.57B1.71B1.8B1.49B1.34B
Accumulated OCI(5.5M)11.5M(45.3M)(108.2M)(12.5M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity1.55B1.34B1.36B1.05B721.2M
Total Debt32.7M1.03B970M846.1M559.3M
Net Debt(712.6M)825.9M807M668.5M407M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.